GI
VYGR icon

GAMMA Investing’s Voyager Therapeutics VYGR Stock Holding History

GAMMA Investing’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$602 Sell
172
-187
-52% -$709 ﹤0.01% 3961
2026
Q1 		$1.39K Buy
+359
New +$1.41K ﹤0.01% 3763
2025
Q2 		– Sell
-50
Closed -$169 – 3896
2025
Q1 		$169 Sell
50
-65
-57% -$304 ﹤0.01% 3762
2024
Q4 		$652 Sell
115
-33
-22% -$213 ﹤0.01% 3528
2024
Q3 		$866 Sell
148
-40
-21% -$291 ﹤0.01% 3295
2024
Q2 		$1.49K Sell
188
-11
-6% -$92 ﹤0.01% 2963
2024
Q1 		$1.85K Buy
199
+50
+34% +$422 ﹤0.01% 2768
2023
Q4 		$1.08K Buy
+149
New +$1.08K ﹤0.01% 2764

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GAMMA Investing's VYGR Position: Q2 2026 in Review

GAMMA Investing reduced its Voyager Therapeutics (VYGR) stake by 52% in Q2 2026, selling an estimated $709 and leaving 172 shares worth $602. The position accounts for ﹤0.01% of the portfolio, ranked #3961.

GAMMA Investing first reported a position in VYGR in Q4 2023 and has held it in 8 quarters since. The position peaked at $1.85K in Q1 2024. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • GAMMA Investing held 172 shares of Voyager Therapeutics worth $602 as of Q2 2026.
  • GAMMA Investing sold 187 Voyager Therapeutics shares in Q2 2026, an estimated $709.
  • Voyager Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3961 holding.
  • GAMMA Investing first reported a position in Voyager Therapeutics in Q4 2023 and has held it in 8 quarters since.
  • GAMMA Investing's Voyager Therapeutics position peaked at $1.85K in Q1 2024.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.